Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 251.00
+12.00 (5.02%)
Apr 14, 2026, 7:45 AM KST
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 49.59 billion as of April 29, 2026. Its market cap has decreased by -67.44% in one year.
Market Cap
49.59B
Enterprise Value
296.56B
Revenue
73.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
251.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 49.59B, an increase of 1,460.76%. That is a compound annual growth rate of 9.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 49.59B | -51.64% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyongbo Pharmaceutical | 163.04B |
| Ilsung Is | 161.68B |
| Jeil Pharma Holdings | 137.09B |
| HANDOK | 135.63B |
| Ildong Holdings | 114.73B |
| CKD Bio | 109.28B |
| Kukje Pharma | 96.93B |
| Enzychem Lifesciences | 76.86B |